Page last updated: 2024-10-29

avapro and Cardiotoxicity

avapro has been researched along with Cardiotoxicity in 2 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Research Excerpts

ExcerptRelevanceReference
" Therefore, it is still needed to search for a safe and effective therapy that can opposite DOX-induced cardiotoxicity."1.51Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK/NF-κB and TGF-β1 pathways. ( El-Said, NT; Mohamed, EA; Taha, RA, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Tepebaşi, MY1
Aşci, H1
Coşan, S1
Sevük, MA1
Karakuyu, NF1
Özmen, Ö1
El-Said, NT1
Mohamed, EA1
Taha, RA1

Other Studies

2 other studies available for avapro and Cardiotoxicity

ArticleYear
Irbesartan has a curative effect on lipopolysaccharide-induced cardiotoxicity by antioxidant and antiapoptotic pathways.
    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2023, Volume: 42, Issue:11

    Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Irbesartan; Lipopolysaccharides; Oxida

2023
Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK/NF-κB and TGF-β1 pathways.
    Naunyn-Schmiedeberg's archives of pharmacology, 2019, Volume: 392, Issue:6

    Topics: Animals; Cardiotoxicity; Caspase 3; Doxorubicin; Electrocardiography; Irbesartan; Male; NF-kappa B;

2019